In Depth 10 Apr 2024 Silencing genes to cure diseases: an in-depth look at siRNA …a component of lipoprotein(a), (Lp(a)) is currently in phase 3 clinical trials. Elevated Lp(a) levels are associated with an increased risk of cardiovascular events. Olpasiran has shown significant promise in… April 10, 2024 - 8 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
More News! 23 Jul 2024 First AKT-targeting drug capivasertib to hit the market, could it open the door for more? …therapy was found to be safe with no serious adverse events during the trial. With an ORR of 30% and a disease control rate (DCR) of 80%, the treatment is… July 23, 2024 - 7 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 10 Apr 2020 Coronavirus Pandemic Bites into European Cancer Research …events such as the London Marathon being postponed. The organization, which funds nearly half the UK’s cancer research, will cut up to 10% off support to existing grants and institutes… April 10, 2020 - 4 minutesmins - By Anita Chakraverty Share WhatsApp Twitter Linkedin Email
Interview 22 Jan 2018 Bravo! An Interview with the CEO of Takeda’s Recent Cell Therapy Target …cells with no response? Blood transfusions have been happening for decades without any serious adverse events and the blood has plenty of cells types to make it complicated; so provided… January 22, 2018 - 6 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
News and Trends 10 Mar 2025 23andMe: the collapse of a genomics giant …ago. What was once a $6 billion company is now a penny stock. Layoffs and mass resignations plagued the genomics giant, and in the most recent turn of events, its… March 10, 2025 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 26 Jan 2021 Oxford’s Covid-19 Vaccine Blazes Trail for Oncolytic Virus Firms …prevents cancer cells from hiding from the immune system — and a pro-inflammatory drug, as well as to block immune-suppressing cells. “These types of multi-armed viruses are really promising and… January 26, 2021 - 7 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Best in Biotech 19 Aug 2025 10 biotech companies you should know about in Spain …genome. PiggyBac functional domains are engineered to provide increased on-target integration while reducing off-target events. FiCAT can be used for in vivo and ex vivo therapies, and also has the… August 19, 2025 - 16 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 20 Dec 2021 The Billion-Euro European Biotech Companies in 2022 …market cap drop by nearly 50% within a year. The wonky market wasn’t the only reason for this, as Galapagos suffered a series of unfortunate events, including a rejection by… December 20, 2021 - 12 minutesmins - By Larissa Warneck-Silvestrin Share WhatsApp Twitter Linkedin Email
News and Trends 1 Jun 2023 Sanofi drug reduces disease activity in relapsing MS …B. The most common adverse events (≥4%) in any frexalimab-treated group were COVID-19 and headache. About frexalimab Frexalimab (SAR441344) is a novel monoclonal antibody that is thought to block the… June 1, 2023 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
In Depth 11 Dec 2023 European patents in biotech: how to prevent invalid patents? …protection in the 17 states. A patent gives you a negative right, as it prevents actions from competitors rather than granting you any specific positive rights. The choice of the… December 11, 2023 - 10 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 14 Nov 2022 Nuance Pharma’s RSV vaccine cleared for trial in China …and is designed to run through the 2022/2023 RSV season with topline results expected mid-2023 if the pre-defined number of lower-respiratory tract disease events has occurred. Under this MVA-BN RSV… November 14, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 25 Apr 2018 Cancer Treatment Targeting DNA Repair is Tested in Humans for the First Time …DNA repair and prevents them from restoring the DNA of tumors cells. As a result, cancer cells continue dividing with damaged DNA, because they are not able to regulate their… April 25, 2018 - 1 minutemin - By Alexander Burik Share WhatsApp Twitter Linkedin Email